Eczema carries double the odds of depression and anxiety

Atopic dermatitis, the most common form of eczema, is often treated as a purely physical nuisance: itching, broken skin, disturbed sleep. Yet clinicians have long suspected it takes a heavier toll, with links to anxiety and depression reported in scattered studies. What nobody had pinned down was the size of that association across the whole evidence base, in both children and adults. This review set out to quantify how strongly atopic dermatitis travels with depression, anxiety and suicidal behaviour, a question with real consequences for how the condition is managed.

The researchers systematically searched three major medical databases, PubMed, Embase and PsychINFO, for studies examining the association between atopic dermatitis and mental health outcomes. They then pooled the results separately for adults and children, calculating combined odds ratios for depression, anxiety and suicidal ideation, and reviewed the smaller body of evidence on completed suicide.

Adults with atopic dermatitis had 2.19 times the odds of depression and 2.19 times the odds of anxiety compared with those without the condition. Children with atopic dermatitis showed a smaller but still significant association with depression, at 1.27 times the odds, though few data were available on anxiety in children. The most striking figure concerned suicidal ideation: adults and adolescents with atopic dermatitis had 4.32 times the odds of experiencing it. Only a few studies examined completed suicide, but the majority of those showed a positive association.

This analysis confirms and sizes an association that had previously been suspected but poorly quantified, and it does so across both age groups. Important caveats remain: the included studies defined depression and anxiety in different ways, few measured eczema severity, and pooled associations of this kind cannot establish which direction the relationship runs. The authors point out that improvement in the skin disease appears to reduce the mental health risks, which suggests the two are genuinely intertwined rather than coincidental, but stronger designs are needed to confirm that.

For anyone living with eczema, or caring for a child who is, this is a reason to treat mood changes as a legitimate part of the condition rather than a separate weakness. The associations here are large enough that the authors argue doctors should actively consider depression, anxiety and suicidal thoughts when treating patients with atopic dermatitis. It is also a reason for optimism of a sort: the evidence suggests that getting the skin under control appears to reduce these psychological risks, making persistence with treatment worth more than the skin alone.